Stay updated on Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.

Latest updates to the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study page now shows recruitment has ended, and new navigation links were added (How to Read a Study Record, Common Questions, How to Join a Study) while the Intervention / Treatment heading was changed to Intervention/Treatment.SummaryDifference0.6%

- Check19 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, representing a new site build. No study details or page content were changed.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision: v3.5.4 is now displayed, replacing the previous Revision: v3.5.3. This reflects a small update to the page rendering without changes to the study data or content.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, indicating a maintenance or release update to the hosting platform rather than a change to the study record content.SummaryDifference0.1%

- Check69 days agoChange DetectedThe site revision changed from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check98 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.